Detalles de la búsqueda
1.
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
Pathologica
; 116(1): 13-21, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482671
2.
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Br J Cancer
; 113(12): 1730-4, 2015 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26633560
3.
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity.
Cancer Res
; 83(14): 2283-2296, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37205627
4.
Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report.
JTO Clin Res Rep
; 4(11): 100555, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38047274
5.
What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review.
Expert Rev Respir Med
; 17(9): 787-803, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817448
6.
Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis.
Cancers (Basel)
; 13(9)2021 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34066817
7.
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma.
Hum Vaccin Immunother
; 17(9): 2972-2980, 2021 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003722
8.
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
Clin Lung Cancer
; 21(6): e567-e571, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591311
9.
Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib.
Cancers (Basel)
; 11(10)2019 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557965
10.
Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.
Target Oncol
; 12(4): 525-533, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28669023
11.
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Cancer Discov
; 7(4): 400-409, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28183697
12.
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.
Lung Cancer
; 99: 31-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565910
13.
Treatment of metastatic neuroendocrine carcinomas based on WHO classification.
Anticancer Res
; 25(6C): 4463-9, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16334127
14.
Optimising management of neutropenia and anaemia in cancer chemotherapy-advances in cytokine therapy.
Crit Rev Oncol Hematol
; 48(Suppl): S39-47, 2003 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14563520
15.
Concurrent Small-Cell Transformation and Emergence of Trans-C797S and T790M Mutations Under Sequential Treatment With EGFR Inhibitors in Lung Adenocarcinoma.
JCO Precis Oncol
; 3: 1-5, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100737
16.
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly.
Support Care Cancer
; 15(9): 1057-66, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17431689
Resultados
1 -
16
de 16
1
Próxima >
>>